Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9135
A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-1992
Closed
01-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9134
A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Advanced Soft-Tissue Sarcoma
Activated
06-01-1992
Closed
06-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9122
Evaluation of 5-Fluorouracil By Intermittent Infusion in Combination with Alpha-Interferon for Patients with Advanced Renal Cell Carcinoma, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
06-01-1992
Closed
10-15-1993
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
SWOG-9138
Evaluation of Fazarabine for Advanced (Stage IV) Non-Small Cell Carcinoma of the Lung, Phase II
Activated
05-15-1992
Closed
07-15-1993
Closed
Phase
Accrual
46%
Published
SWOG Clinical Trial Number
SWOG-9058
A Phase II Trial of Intravenous Vinorelbine (Navelbine®) in Previously Untreated Extensive Small Cell Lung Carcinoma
Research Committee(s)
Lung Cancer
Activated
05-15-1992
Closed
06-01-1995
Closed
Phase
Accrual
5%
SWOG Clinical Trial Number
SWOG-9015
A Randomized Trial of Pre- and Post-Operative Chemotherapy Compared to Surgery Alone for Patients with Operable Non Small Cell Carcinoma of the Lung, Phase III
Research Committee(s)
Lung Cancer
Activated
05-15-1992
Closed
03-15-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9019
A Pilot Study of Chemotherapy Plus Radiation Therapy for Selected IIIb (No Malignant Effusion) Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
04-15-1992
Closed
12-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9051
Pilot Evaluation of Combined Hepatic Chemoembolization and Systemic Chemotherapy with 5-FU and Folinic Acid for Metastatic Adenocarcinoma of the Colon and Rectum, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1992
Closed
04-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9035
Randomized Trial of Adjuvant Immunotherapy with an Allogeneic Melanoma Vaccine for Patients with Intermediate Thickness, Node Negative Malignant Melanoma (T3N0M0), Phase III.
Research Committee(s)
Melanoma
Activated
04-15-1992
Closed
11-15-1996
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-9137
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9151
Evaluation of Topotecan in Hepatoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
02-01-1992
Closed
06-15-1993
Closed
Phase
Accrual
14%
SWOG Clinical Trial Number
SWOG-9115 (EST-1192) (INT-0127)
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9139
Adjuvant Therapy of Primary Osteogenic Sarcomas, Phase II
Activated
12-15-1991
Closed
12-01-1996
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
SWOG-9119
Primary Chemotherapy of Poor Prognosis Soft Tissue Sarcomas, Phase II
Activated
12-15-1991
Closed
06-15-1998
Closed
Phase
Accrual
64%
Published
SWOG Clinical Trial Number
SWOG-9136
Biologic Parameters in Soft Tissue Sarcomas: A Companion Study to Select Southwest Oncology Group Clinical Trials with Soft Tissue Sarcoma Patients
Research Committee(s)
Sarcoma
Activated
12-15-1991
Closed
06-15-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9031
A Double Blind Placebo Controlled Trial of Daunomycin and Cytosine Arabinoside With or Without rhG-CSF in Elderly Patients With Acute Myeloid Leukemia
Research Committee(s)
Leukemia
Activated
11-15-1991
Closed
01-15-1995
Closed
Phase
Accrual
18%
Published
SWOG Clinical Trial Number
SWOG-9118
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9110
A Phase II Evaluation of Didemnin B In Central Nervous System Tumors
Research Committee(s)
Brain Cancer
Activated
11-01-1991
Closed
11-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9060
A Pilot Study Evaluation of Multimodality Treatment of Local Regional Esophageal Carcinoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
11-01-1991
Closed
03-01-1993
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
SWOG-9030
Phase II Study of High Dose ARA-C/Mitoxantrone for the Treatment of Relapsed/Refractory Acute Lymphocytic Leukemia
Research Committee(s)
Leukemia
Activated
11-01-1991
Closed
05-15-1994